T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Citizens Financial Group
CFG
$31.3B
| $248M | 0.02% |
5,238,354
-2,150,955
| -29% | -$104M |
|
502
Boston Scientific
BSX
$75.5B
| $247M | 0.02% |
5,815,950
-19,329
| -0.3% | -$812K |
|
503
Ralph Lauren
RL
$23.1B
| $246M | 0.02% |
2,073,289
+17,507
| +0.9% | +$2.1M |
|
504
Diamondback Energy
FANG
$55.2B
| $246M | 0.02% |
2,282,625
-199,439
| -8% | -$21.6M |
|
505
ONE Gas
OGS
$5.12B
| $245M | 0.02% |
3,160,604
-479,270
| -13% | -$33.4M |
|
|
JOYY
506
JOYY Inc
JOYY
$3.7B
| $244M | 0.02% |
5,369,156
+750,600
| +16% | +$38.7M |
|
507
Selective Insurance
SIGI
$5.63B
| $244M | 0.02% |
2,971,993
-78,832
| -3% | -$6.25M |
|
508
Warner Music
WMG
$13.1B
| $243M | 0.02% |
5,624,866
+665,564
| +13% | +$29.9M |
|
509
Mattel
MAT
$4.25B
| $240M | 0.02% |
11,148,139
-102,987
| -0.9% | -$2.16M |
|
510
SouthState Bank Corp
SSB
$10.8B
| $240M | 0.02% |
2,995,073
-68,975
| -2% | -$5.48M |
|
511
RTX Corp
RTX
$296B
| $240M | 0.02% |
2,785,200
+47,151
| +2% | +$4.11M |
|
512
Darling Ingredients
DAR
$10B
| $240M | 0.02% |
3,458,564
+192,691
| +6% | +$14M |
|
513
Blackrock
BLK
$182B
| $240M | 0.02% |
261,606
-4,390
| -2% | -$4.01M |
|
514
Arvinas
ARVN
$585M
| $239M | 0.02% |
2,910,606
+353,452
| +14% | +$28.8M |
|
|
CFLT
515
DELISTED
Confluent
CFLT
| $239M | 0.02% |
3,128,975
+1,209,830
| +63% | +$87.2M |
|
516
Southwest Gas
SWX
$6.7B
| $237M | 0.02% |
3,388,301
-95,197
| -3% | -$6.56M |
|
517
ESCO Technologies
ESE
$7.7B
| $237M | 0.02% |
2,636,105
-60,748
| -2% | -$5.25M |
|
518
Xencor
XNCR
$1.69B
| $237M | 0.02% |
5,908,683
-23,490
| -0.4% | -$891K |
|
519
Infosys
INFY
$50.3B
| $237M | 0.02% |
9,364,573
-1,612,774
| -15% | -$37.5M |
|
520
ICICI Bank
IBN
$106B
| $237M | 0.02% |
11,960,963
+716,205
| +6% | +$14.2M |
|
521
Belden
BDC
$5.35B
| $235M | 0.02% |
3,579,702
-442,026
| -11% | -$27.7M |
|
522
Brighthouse Financial
BHF
$3.44B
| $234M | 0.02% |
4,520,762
-280,215
| -6% | -$14.3M |
|
523
EQT Corp
EQT
$33.5B
| $230M | 0.02% |
10,563,319
-14,116,241
| -57% | -$295M |
|
524
Fate Therapeutics
FATE
$310M
| $230M | 0.02% |
3,933,938
-22,557
| -0.6% | -$1.28M |
|
525
AutoZone
AZO
$50.5B
| $227M | 0.02% |
108,222
-17,747
| -14% | -$33M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.